|
OMIM |
Link |
Information gain |
01 |
|
EKD1
|
[NCBI]
|
0.0238109
|
|
|
centralopathic epilepsy
|
[NCBI]
|
0.00583383
|
|
|
PPR
|
[NCBI]
|
0.00387299
|
|
|
EIG
|
[NCBI]
|
0.00290237
|
|
|
LKS
|
[NCBI]
|
0.0019116
|
|
|
S CRAMP
|
[NCBI]
|
0.00179948
|
|
|
ECA1
|
[NCBI]
|
0.00108503
|
|
|
convulsions, benign familial infantile, 1
|
[NCBI]
|
0.000959946
|
|
|
epilepsy, myoclonic, benign adult familial, type 1
|
[NCBI]
|
0.000959946
|
|
|
myoclonic epilepsy of unverricht and lundborg
|
[NCBI]
|
0.000898827
|
|
|
ETL2
|
[NCBI]
|
0.000867747
|
|
|
TS
|
[NCBI]
|
0.000676208
|
|
|
restless legs syndrome, susceptibility to, 1
|
[NCBI]
|
0.000457195
|
|
|
severe cutaneous adverse reaction, susceptibility to
|
[NCBI]
|
0.000410406
|
|
|
valproate embryopathy, susceptibility to
|
[NCBI]
|
0.000292707
|
|
|
SMEI
|
[NCBI]
|
0.000269236
|
|
|
PNKD1
|
[NCBI]
|
0.000221303
|
|
|
CPI
|
[NCBI]
|
0.000189903
|
|
|
JME
|
[NCBI]
|
0.000161612
|
|
|
ETM1
|
[NCBI]
|
0.000161612
|
|
|
NPY
|
[NCBI]
|
0.000149099
|
|
|
SPS
|
[NCBI]
|
0.00014076
|
|
|
fibromatosis, gingival, with hypertrichosis
|
[NCBI]
|
0.000137531
|
|
|
gamstorp-wohlfart syndrome
|
[NCBI]
|
0.000137531
|
|
|
SHBG
|
[NCBI]
|
0.000129693
|
|
|
succinic semialdehyde dehydrogenase deficiency
|
[NCBI]
|
0.000125739
|
|
|
AS
|
[NCBI]
|
0.000116739
|
|
|
ventricular tachycardia, familial
|
[NCBI]
|
0.000105994
|
|
|
GEPD
|
[NCBI]
|
0.000105994
|
|
|
epilepsy, childhood absence, 2
|
[NCBI]
|
0.000105994
|
|
|
paroxysmal extreme pain disorder
|
[NCBI]
|
9.41247e-05
|
|
|
FEB8
|
[NCBI]
|
9.41247e-05
|
|
|
alternating hemiplegia of childhood
|
[NCBI]
|
8.64358e-05
|
|
|
myoclonic epilepsy, neonatal, with suppression-burst pattern
|
[NCBI]
|
8.07323e-05
|
|
|
MTATP8
|
[NCBI]
|
7.93629e-05
|
|
|
epilepsy, nocturnal frontal lobe, type 1
|
[NCBI]
|
6.92246e-05
|
|
|
ABCC1
|
[NCBI]
|
6.81694e-05
|
|
|
ornithine transcarbamylase deficiency, hyperammonemia due to
|
[NCBI]
|
6.68306e-05
|
|
|
encephalopathy, neonatal severe, due to mecp2 mutations
|
[NCBI]
|
6.39402e-05
|
|
|
chondrodysplasia punctata, autosomal dominant
|
[NCBI]
|
6.1712e-05
|
|
|
CDPX1
|
[NCBI]
|
6.1712e-05
|
|
|
EA1
|
[NCBI]
|
6.1712e-05
|
|
|
EBN1
|
[NCBI]
|
5.61449e-05
|
|
|
ALDH5A1
|
[NCBI]
|
5.52921e-05
|
|
|
SJS1
|
[NCBI]
|
5.45703e-05
|
|
|
MAFD6
|
[NCBI]
|
5.41154e-05
|
|
|
FHM1
|
[NCBI]
|
5.04468e-05
|
|
|
glucose transport defect, blood-brain barrier
|
[NCBI]
|
4.92345e-05
|
|
|
GABRA1
|
[NCBI]
|
4.86555e-05
|
|
|
hyperekplexia, hereditary
|
[NCBI]
|
4.8089e-05
|
|
|
SCN1A
|
[NCBI]
|
4.21172e-05
|
|
|
CHAC
|
[NCBI]
|
4.14791e-05
|
|
|
ABCB1
|
[NCBI]
|
4.09209e-05
|
|
|
andersen cardiodysrhythmic periodic paralysis
|
[NCBI]
|
4.06894e-05
|
|
|
AD
|
[NCBI]
|
3.90491e-05
|
|
|
EPHX1
|
[NCBI]
|
3.64346e-05
|
|
|
WHS
|
[NCBI]
|
3.59023e-05
|
|
|
CLN3
|
[NCBI]
|
3.53056e-05
|
|
|
citrullinemia, classic
|
[NCBI]
|
3.36201e-05
|
|
|
adrenoleukodystrophy, autosomal neonatal form
|
[NCBI]
|
3.15853e-05
|
|
|
NR1I2
|
[NCBI]
|
2.94849e-05
|
|
|
HHF2
|
[NCBI]
|
2.89025e-05
|
|
|
RTT
|
[NCBI]
|
2.86805e-05
|
|
|
TAGLN2
|
[NCBI]
|
2.76297e-05
|
|
|
NOVA2
|
[NCBI]
|
2.52049e-05
|
|
|
CACNA2D1
|
[NCBI]
|
2.43115e-05
|
|
|
PCMT1
|
[NCBI]
|
2.35471e-05
|
|
|
VKORC1
|
[NCBI]
|
2.35471e-05
|
|
|
MECP2
|
[NCBI]
|
2.28934e-05
|
|
|
SLC12A2
|
[NCBI]
|
2.28792e-05
|
|
|
SLC18A1
|
[NCBI]
|
2.22862e-05
|
|
|
DBI
|
[NCBI]
|
2.14986e-05
|
|
|
ABCG2
|
[NCBI]
|
2.07601e-05
|
|
|
KCNQ2
|
[NCBI]
|
1.96826e-05
|
|
|
ATP1A2
|
[NCBI]
|
1.9351e-05
|
|
|
GABRG2
|
[NCBI]
|
1.9351e-05
|
|
|
CYP2C9
|
[NCBI]
|
1.9351e-05
|
|
|
CNR1
|
[NCBI]
|
1.9039e-05
|
|
|
HSD17B4
|
[NCBI]
|
1.82013e-05
|
|
|
SLC2A1
|
[NCBI]
|
1.82013e-05
|
|
|
CYP2C19
|
[NCBI]
|
1.82013e-05
|
|
|
MG
|
[NCBI]
|
1.81141e-05
|
|
|
DBH
|
[NCBI]
|
1.77092e-05
|
|
|
tay-sachs disease, ab variant
|
[NCBI]
|
1.77092e-05
|
|
|
AHO
|
[NCBI]
|
1.65862e-05
|
|
|
ZS
|
[NCBI]
|
1.56591e-05
|
|
|
HLA-B
|
[NCBI]
|
1.56132e-05
|
|
|
FASN
|
[NCBI]
|
1.54589e-05
|
|
|
BDNF
|
[NCBI]
|
1.53158e-05
|
|
|
MAOB
|
[NCBI]
|
1.53091e-05
|
|
|
GCDH
|
[NCBI]
|
1.53091e-05
|
|
|
DNAJC5
|
[NCBI]
|
1.51636e-05
|
|
|
SLC1A2
|
[NCBI]
|
1.42467e-05
|
|
|
GRIA1
|
[NCBI]
|
1.40125e-05
|
|
|
CACNA1A
|
[NCBI]
|
1.33686e-05
|
|
|
FLNA
|
[NCBI]
|
1.32688e-05
|
|
|
EGF
|
[NCBI]
|
1.31313e-05
|
|
|
PRL
|
[NCBI]
|
1.30537e-05
|
|
|
OTC
|
[NCBI]
|
1.26213e-05
|
|
|
DFFB
|
[NCBI]
|
1.26213e-05
|
|
|
PPARA
|
[NCBI]
|
1.25362e-05
|
|
|
CRH
|
[NCBI]
|
1.19182e-05
|
|
|
HD
|
[NCBI]
|
1.17327e-05
|
|
|
protein c deficiency, congenital thrombotic disease due to
|
[NCBI]
|
1.15351e-05
|
|
|
MTTL1
|
[NCBI]
|
1.12643e-05
|
|
|
PTH
|
[NCBI]
|
1.10627e-05
|
|
|
MJD
|
[NCBI]
|
1.04605e-05
|
|
|
HLA-A
|
[NCBI]
|
1.04204e-05
|
|
|
MAPK1
|
[NCBI]
|
9.29417e-06
|
|
|
PC
|
[NCBI]
|
8.95846e-06
|
|
|
TNF
|
[NCBI]
|
7.34445e-06
|
|
|
IHH
|
[NCBI]
|
6.81453e-06
|
|
|
SLC18A3
|
[NCBI]
|
6.54959e-06
|
|
|
KCNH2
|
[NCBI]
|
6.04539e-06
|
|
|
GTS
|
[NCBI]
|
5.939e-06
|
|
|
PI
|
[NCBI]
|
4.47746e-06
|
|
|
EGFR
|
[NCBI]
|
4.14306e-06
|
|
|
CJD
|
[NCBI]
|
4.01805e-06
|
|
|
MDD
|
[NCBI]
|
3.99502e-06
|
|
|
BCHE
|
[NCBI]
|
3.9273e-06
|
|
|
GFAP
|
[NCBI]
|
3.42794e-06
|
|
|
KLK3
|
[NCBI]
|
3.21633e-06
|
|
|
TPO
|
[NCBI]
|
2.94729e-06
|
|
|
LCAT
|
[NCBI]
|
2.90595e-06
|
|
|
TH
|
[NCBI]
|
2.22018e-06
|
|
|
CTGF
|
[NCBI]
|
2.16802e-06
|
|
|
EPO
|
[NCBI]
|
2.10686e-06
|
|
|
VIP
|
[NCBI]
|
1.95077e-06
|
|
|
AVP
|
[NCBI]
|
1.90746e-06
|
|
|
PD
|
[NCBI]
|
1.58979e-06
|
|
|
ACHE
|
[NCBI]
|
1.47305e-06
|
|
|
ADCYAP1
|
[NCBI]
|
1.29826e-06
|
|
|
SLE
|
[NCBI]
|
9.68644e-07
|
|
|
XDH
|
[NCBI]
|
9.09681e-07
|
|
|
NGFB
|
[NCBI]
|
8.57198e-07
|
|
|
SLC6A3
|
[NCBI]
|
8.54773e-07
|
|
|
CHAT
|
[NCBI]
|
7.48526e-07
|
|
|
RNASE3
|
[NCBI]
|
6.3367e-07
|
|
|
APOE
|
[NCBI]
|
6.04518e-07
|
|
|
APOB
|
[NCBI]
|
5.18778e-07
|
|
|
GDNF
|
[NCBI]
|
4.87685e-07
|
|
|
GNRH1
|
[NCBI]
|
4.45213e-07
|
|
|
CAT
|
[NCBI]
|
2.90359e-07
|
|
|
AR
|
[NCBI]
|
1.64345e-07
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
1.44783e-07
|
|
|
G6PD
|
[NCBI]
|
1.13668e-07
|
|
|
TG
|
[NCBI]
|
6.59289e-08
|
|